The FDA has approved GlaxoSmithKline’s multiple myeloma drug Blenrep, a first-in-class potential blockbuster that will be used in advanced disease. Blenrep (belantamab mafodotin) has been ...

The trial evaluated Blenrep (belantamab mafodotin), in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care, bortezomib plus PomDex. A pre-specified interim ...

Less than two years after pulling multiple myeloma therapy Blenrep off most markets around the world, GSK has filed for approval of the drug in the EU once again, hoping to restore its blockbuster ...

The number of each atom collected is shown in the "Atoms Collected" area of the side panel. To create a molecule, make sure you have the right number of each atom and then select the correct “Create ...

(RTTNews) - Drug maker GSK plc (GSK, GSK.L) announced Tuesday that Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple myeloma have been accepted for regulatory review in ...

Berenberg estimates an around 9% return on R&D investment from its current late-stage pipeline dominated by its multiple myeloma treatment Blenrep and its severe asthma drug depemokimab ...

ATP consists of an adenosine base (blue), a ribose sugar (pink) and a phosphate chain. The high-energy phosphate bond in this phosphate chain is the key to ATP's energy storage potential. Cells ...

Deoxyribonucleic acid (DNA) is a molecule that encodes an organism's genetic blueprint. In other words, DNA contains all of the information required to build and maintain an organism. DNA was ...

A certified sleep science coach and mattress expert, JD has been reviewing online mattresses professionally for the past five years. During that time, he's tested well over 150 beds and dedicated ...

The new research, however, paints a different picture. The team discovered a gene that produces an RNA molecule—not a protein—controls where dark pigments are made during butterfly metamorphosis.